echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > [heavyweight] Huizhi new era, empowering new journey 2019 China Pharmaceutical Health Industry Development Conference and the 4th China Pharmaceutical R & D Innovation Summit (PDI Conference) grand opening

    [heavyweight] Huizhi new era, empowering new journey 2019 China Pharmaceutical Health Industry Development Conference and the 4th China Pharmaceutical R & D Innovation Summit (PDI Conference) grand opening

    • Last Update: 2019-06-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, President Xi Jinping emphasized that health for all is the common vision of mankind and an important part of building a community of human destiny It is also an important part of promoting global health and implementing the 2030 agenda for sustainable development In recent years, with the active promotion of the national level, the health industry with great potential has become a new industry star In 2016, the State Council issued the outline of healthy China 2030 plan, which raised "healthy China" to the strategic position of front-line development The report of the 19th National Congress of the Communist Party of China once again pointed out that the healthy China strategy should be implemented In June 2019, the general office of the State Council issued the key tasks of deepening the reform of the medical and health system in 2019, requiring the formulation of opinions on the implementation of the healthy China action, the healthy China action (2019-2030).. "Healthy China" strategy was upgraded again, becoming an important engine for the development of the health industry On June 21, 2019 China Pharmaceutical Health Industry Development Conference and the fourth China Pharmaceutical R & D Innovation Summit (PDI Conference) was held in Nanping, Chongqing International Convention and Exhibition Center Mr Qu Fenghong, deputy secretary-general of the CPPCC National Committee and full-time vice chairman of the CPC Central Committee, Mr Du liming, deputy director of the Standing Committee of Chongqing Municipal People's Congress, Mr Fan Daiming, academician of the Chinese Academy of engineering, vice president of the Chinese Academy of engineering and President of Xijing digestive disease hospital, Mr Dan Zhengzheng, director of Chongqing Medical Insurance Bureau, Mr Zheng Xiangdong, Secretary of the south bank District Committee of the CPC and Secretary of the Party Working Committee of Chongqing Economic Development Zone, Mr Zheng Xiangdong, South Bank of the CPC Mr Chen Yiqing, deputy secretary of the District Committee and district president of the District People's government, Mr Wang Maochun, deputy secretary of the Nanan District Committee of the Communist Party of China and director of Chongqing Economic Development Zone Management Committee, Mr Li Xiaoping, deputy director of Chongqing food and drug administration, Mr Yao Shu, full-time deputy chairman of Chongqing Municipal Committee of the agricultural labor party, Ms Wei Xiaohong, member of the Standing Committee of the Nanan District and director of the publicity and Communication Department of the District, Ms Mou Chengyong, deputy director of the Standing Committee of the Nanan District People's Congress, and people of the Nanan District Mr Chen Jiong, deputy district head of the people's Government of Nan'an District, Mr LV Yi, deputy district head of the people's Government of Nan'an District, Mr Zhang Jin, deputy director of the Management Committee of Chongqing Economic and Technological Development Zone, Mr Lu Tao, vice president of China Pharmaceutical University, Mr Rui Guozhong, executive vice president of China Association for technology entrepreneurship and Secretary General of the National Union of biomedical parks (CBCA), Ministry of science and technology and other leading guests attended the opening ceremony of the conference, and Ms Sha Qing, xinhuanet.com, assumed that Presided over by the conference More than 2000 elites of industry, learning, research and capital gathered to share the feast PDI exhibition combines the construction of intelligent bridge, the gathering of top pharmaceutical enterprises in the industry, and the release of big data achievements, which is unprecedented Opening ceremony The summit is jointly guided by China Pharmaceutical University, China Pharmaceutical Enterprise Management Association, Chongqing pharmaceutical association, Chongqing Economic and Information Technology Commission, Chongqing Economic and Technological Development Zone Management Commission, Chongqing Nan'an District People's government, and co sponsored by yaozhi.com, Xinhua health think tank, Southwest University, Chongqing Institute of traditional Chinese medicine and Chongqing Medical Insurance Research Association With the theme of "Huizhi new era, empowering new journey", we have carried out 2-day in-depth exchanges from "pharmaceutical R & D innovation and enterprise development", "medical insurance hot issues discussion", "pharmaceutical development and high-end innovative personnel training", "medical and health industry project investment and financing", to respond to hot issues, deepen industrial innovation, empower industry development, and help the pharmaceutical industry to advance Internationally, boost the construction of "healthy China" People's daily, dayu.com, hualong.com, fenghuang.com, guangming.com, today's headlines, netease.com, Sina News, Chongqing TV, Nan'an TV, Chongqing daily, Chongqing Morning News, Nan'an news, China News Agency, medicine guide, Chinese medicine and national medicine journal, aoya.com, Biovalley, YanRuYu, medicine research, Chinese society of Gerontology and geriatrics, Tianjin Pharmaceutical Research Institute, convergence More than 100 industries and mass media reports, including Nanyao pharmaceutical and Huiyao coffee, and 10 high-end interviews on Xinhuanet Com, have a direct conversation with experts and scholars, and listen to the voice of the industry's leading edge The special page of xinhuanet.com has a live broadcast of the grand occasion of the conference, sharing the conference's wisdom with people outside Lu Yi, vice president of Nan'an District People's Government of Chongqing, delivered a speech at the opening of the conference, expressing his support for the conference held in Nan'an and affirming that the conference has a strong role in promoting the research and development of the pharmaceutical industry in Chongqing and Nan'an District At present, Nan'an District is also actively planning and constructing Jiangnan New City, the city's large health cluster demonstration area, building a large health industry cluster integrating precision medicine, health care consumption and medicine, and building a comprehensive, ecological and full cycle system In addition, Nan'an District has gathered pharmaceutical enterprises such as Institute of traditional Chinese medicine, TongJunGe, Sinopharm group, etc., with the advantages of multiple policies such as western development, pilot Free Trade Zone, China Singapore strategic internet connectivity project, and is willing to build a good development environment for enterprises Lu Yi, vice president of Nan'an District People's Government of Chongqing, delivered a speech to the conference, and Du liming, deputy director of the Standing Committee of Chongqing Municipal People's Congress, pointed out that the pharmaceutical R & D Innovation Summit has been held in Chongqing for four years and played a positive role in promoting the development of the industry Chongqing attaches great importance to the development of medical and health industry, promotes the development of medical and health industry in Chongqing to scale, feature and pattern, and strives to improve the quality and effect of industrial development Chongqing, as the economic center of the upper reaches of the Yangtze River, is taking the pharmaceutical industry as one of the strategic emerging industries in Chongqing Chongqing attaches great importance to strengthening the links among various departments, medical institutions and enterprises, supervising the whole process of medical insurance expenditure, promoting the comprehensive reform of public hospitals, exploring the reform of medical insurance drug payment, and using big data technology to promote the construction of social security and medical insurance service capacity Mr Du liming, deputy director of the Standing Committee of Chongqing Municipal People's Congress delivered a speech to Mr Qu Fenghong, Deputy Secretary General of the CPPCC National Committee and full-time vice chairman of the Central Committee of the Agricultural Labor Party Speech and wish the conference a complete success He mentioned that the great health industry has made great progress under the promotion of policies Health China has risen to the national strategy The national health status has become an important indicator reflecting the overall development, health level and population quality of a country and region As a "sunrise industry", medical and health industry is full of infinite opportunities and challenges In line with the theme of the three medical linkage reform, the elites of the pharmaceutical industry gathered at the conference to conduct in-depth analysis and innovation in combination with policy guidance This is of far-reaching significance to improve their comprehensive strength, boost the development of the industry and realize strategic transformation Mr Qu Fenghong, Deputy Secretary General of the CPPCC National Committee and full-time vice chairman of the Central Committee of the agricultural labor party, delivered a speech 02 innovation benchmarking and blue ocean wisdom sharing leading new development, successively undertaking national 973, 863, major new drug creation, natural science fund and other topics It has won 1 National Science and technology progress and innovation team award, 1 first, second and third prizes, 1 National Technology Invention Award, 38 national invention patents and 1 national new drug certificate Academician fan Daiming, academician of Chinese Academy of engineering, vice president of Chinese Academy of engineering and President of Xijing digestive hospital, presented a wonderful report "reverse research of pharmacy" at this conference Academician fan mentioned that the value of drugs can be explored in depth, and the magic of reverse pharmaceutical research, such as "one drug for multiple use", "old drug for new use", "indirect drug use", "integrated drug use", is endless The way of drug research and development, solidification thinking is a big obstacle However, reverse thinking not only brings new possibilities for drug research, but also brings new vitality to some drugs In the follow-up to the report, academician fan sent a message to the medical people Don't be afraid to walk on the dead end Few people can dig out surprises on the way, adjust the direction at any time, so as to reach the distance In recent years, the thinking of pharmaceutical industry reform is centered on "innovation" Innovation has become the first driving force for development and strategic support for the pharmaceutical industry At the conference, the innovation achievements of the industry and enterprises that have attracted much attention were solemnly released Following the top 100 of 2019 China Pharmaceutical R & D comprehensive strength, top 100 of 2019 China chemical R & D strength, top 50 of 2019 China TCM R & D strength and top T of 2019 China biopharmaceutical R & D strength Op50 and China's top 20 cros in 2019, and presented awards to the winning enterprises on the spot More than 200 enterprises, such as Jiangsu Hengrui Pharmaceutical Co., Ltd., "R & D first brother", Zhengda Tianqing Pharmaceutical Group Co., Ltd., Tianshili Pharmaceutical Group Co., Ltd., the leader of traditional Chinese medicine, and cro Wuxi pharmaceutical mingkant new drug development Co., Ltd., have won awards (see the end of the article for details of the list) in terms of the interpretation of innovation, these industry benchmark enterprises give the best answer, and they are the vanguard in the blue ocean of medicine It is an important strategic choice for the development of enterprises in the current era to issue the list of on-site cooperation for win-win results At the conference, yaozhi.com, one of the organizers, reached long-term cooperation with Chongqing Kalan Pharmaceutical Co., Ltd., Shandong Bainuo Pharmaceutical Co., Ltd and changlongjinkai International Enterprise Park, and awarded the license on site During the licensing conference of strategic partners of yaozhi.com, Professor Lu Tao, vice president of China Pharmaceutical University and Mr Li Tianquan, vice president of yaozhi.com, edited the new book "big data of 40 years of Chinese pharmaceutical R & D", which recorded 40 years of epic of pharmaceutical development Mr Shi Yuanping, chairman of yaozhi.com, director of the editorial board of the main creative book, Mr Li Xiaobing, deputy director of Chongqing mental health center, Mr Hu Changhua, Dean of Southwest University School of pharmacy, and Mr Kuang luojun, deputy general manager of China Pharmaceutical Science and Technology Press, the publisher, all attended the release ceremony and witnessed the important moment of the new book Release ceremony of new book "big data of China's pharmaceutical R & D in 40 years" In 2018, the new medical insurance bureau was established, and a series of subsequent policies were launched, which brought great pressure to the industry Hu Dayang, vice president of China Medical Insurance Research Association, President of Jiangsu Medical Insurance Research Association and President of Nanjing Yunkang medical insurance college, brought the theme report of "encouraging medical Innovation: responsibility and mission of medical insurance in the new era", discussed the current medical insurance measures in depth, and proposed Innovation is the responsibility and mission of medical insurance in the new era Medical insurance is undergoing a dynamic adjustment mode of "cage for birds" Inferior drugs and low-value drugs will be transferred out of medical insurance to make room for good drugs and innovative drugs, which undoubtedly gives solid support to innovative enterprises Hu Wenhao, professor and doctoral supervisor of Sun Yat sen University and Dean of the school of pharmacy, brought the theme report "multicomponent reaction and its application in drug research and development" Based on the research of innovative sources, he pointed out that drug chirality plays an important role in drug research, and the development of high-efficiency chiral synthesis technology is a frontier research field Hu Wenhao, currently vice president of China Medical Insurance Research Association, President of Jiangsu Medical Insurance Research Association, Professor, doctoral supervisor of Sun Yat sen University, President of Nanjing Yunkang medical security college, and President of the school of medicine, focuses on the industry shock and the declining situation under the impact of the wisdom of the main forum of the new journey, and the parallel sub forums and the exhibition site are also blooming In the afternoon of the general assembly, four forums will be set up separately In order to break through the difficult problems of the times from all aspects, the guests at the meeting have made suggestions and suggestions and worked together for development The theme of the 4th China Pharmaceutical R & D Innovation Summit in 2019 is "strategic selection and project approval of enterprises under the new policy", which brings together more than 20 experts to bring wonderful reports From the perspectives of "new technology, new thinking and new methods", new policy analysis, international perspective and enterprise transformation, the forum aims to enlighten enterprises on how to play their own advantages, determine and implement strategic planning, and propose
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.